Digest Network Come funziona
Network
/
Società
Le
Non verificato

Leukogene Therapeutics Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIgiene alimentareIndustriaSalute

3 comunicati stampa

Guarda tutti i comunicati
12/11/2025
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Oncologia
Industria
Leukogene Therapeutics Receives Strategic Funding from South Carolina Research Authority to Accelerate Development of Its Cancer Immunotherapy Pipeline
Fonte
Leukogene Therapeutics Inc.
Emittente
Business Wire
1.00
0
05/11/2025
Industria
Biotecnologia
Igiene alimentare
Farmaceutica
Salute
U.S. FDA Grants Orphan Drug Designation to Leukogene Therapeutics’ M2T-CD33 (LTI-214) for the Treatment of Acute Myeloid Leukemia
Fonte
Leukogene Therapeutics Inc.
Emittente
Business Wire
1.00
0
09/12/2024
Mercato del lavoro
Oncologia
Salute
Biotecnologia
Sanità
Farmaceutica
Leukogene Therapeutics Welcomes Industry Veteran and Leader Dr. Sandeep Gupta as Its Chief Executive Officer
Fonte
Leukogene Therapeutics Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0